Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|13|4|428-444

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.13, Iss.4, 2018-11, pp. : 428-444

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Crosstalk of oncogenic and prostanoid signaling pathways

By Müller Rolf  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 8, 2004-08 ,pp. : 429-444

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen signaling and prediction of endocrine therapy

By Hayashi Shin-ichi   Yamaguchi Yuri  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 27-31

Springer Publishing Company

Access to resources Recommend Favorite

Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2325-2330

Spandidos Publications

Access to resources Recommend Favorite

Crosstalk between the p38 and TGFβ signaling pathways through TβRI, TβRII and Smad3 expression in plancental choriocarcinoma JEG3 cells

By          

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1307-1311

Spandidos Publications

Access to resources Recommend Favorite

Differential crosstalk between the AMPK and PI3K/Akt pathways in breast cancer cells of differing genotypes: Leptin inhibits the effectiveness of AMPK activation

By El-Masry Omar S.   Al-Sakkaf Kaltoom   Brown Barry L.   Dobson Pauline R.M.  

Oncology Reports, Vol. 34, Iss. 4, 2015-10 ,pp. : 1675-1680

Spandidos Publications

Access to resources Recommend Favorite